Effect of garlic on some types of adipokines in metabolic syndrome

The effect of garlic tablets on serum concentrations of Adiponectin , INL6 and TNF alpha in subjects with metabolic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138706121179N1

Enrollment

Registered

2009-01-01

Start date

2008-06-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome. E65-E68

Interventions

Intervention 1: No intervention. Intervention 2: Placebo. Intervention 3: Garlic tablets.

Treatment - Drugs

No intervention

Placebo

Garlic tablets

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All people who will be diagnosed to have metabolic syndrome based on ATPIII criteria , more than 18 years old. Exclusion criteria: Presence of acute or chronic inflammatory or infectious diseases, taking anti inflammatory medications or other drugs affecting insulin resistance.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum Adiponectin. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: ELISA.;Serum TNF. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: ELISA.;Serum IL6. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: ELISA.	—

Secondary

Measure	Time frame
Serum lipid Concentrations(TG, Cholesterol, HDL-C). Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: Enzymatic methods.;Fasting Plasma Glucose. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: Enzymatic methods.;Blood pressure. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: standard methods for BP.;Waist circomferance. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: standard methods.	—

Measure

Time frame

Serum lipid Concentrations(TG, Cholesterol, HDL-C). Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: Enzymatic methods.;Fasting Plasma Glucose. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: Enzymatic methods.;Blood pressure. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: standard methods for BP.;Waist circomferance. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: standard methods.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaranak Sharifi

Zanjan Metabolic Diseases Research Center

faranaksharifi@hotmail.com+98 24 1727 0815

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026